Home
About
Overview
Sharing Data
ORCID
Help
History (29)
Colpocleisis: a safe, minimally invasive option for pelvic organ prolapse.
Brief report: autistic symptoms, developmental regression, mental retardation, epilepsy, and dyskinesias in CNS folate deficiency.
Evaluation of food effect on pharmacokinetics of vismodegib in advanced solid tumor patients.
Neuroimmunology and the control of T cell migration.
Optimising the design of phase II oncology trials: the importance of randomisation.
See All 29 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Optimising the design of phase II oncology trials: the importance of randomisation.
Optimising the design of phase II oncology trials: the importance of randomisation. Eur J Cancer. 2009 Jan; 45(2):275-80.
View in:
PubMed
subject areas
Antineoplastic Agents
Clinical Trials, Phase II as Topic
Humans
Neoplasms
Observer Variation
Random Allocation
Randomized Controlled Trials as Topic
Research Design
Sample Size
Treatment Outcome
authors with profiles
Mark Ratain